Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Molecular Imaging and Biology
|
October 2, 2020
[<sup>18</sup>F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer
Felix Dietlein, Peter Mueller, Carsten Kobe, et al.
Nature Genetics
|
February 5, 2020
Identification of cancer driver genes based on nucleotide context
Felix Dietlein, Donate Weghorn, Amaro Taylor-Weiner, et al.
Molecular Imaging and Biology
|
August 9, 2021
Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer
Sergio Muñoz Vázquez, Heike Endepols, Thomas Fischer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
An <sup>89</sup>Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients
Felix Dietlein, Carsten Kobe, Sergio Muñoz Vázquez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 21, 2019
An <sup>18</sup>F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with <sup>18</sup>F-JK-PSMA-7 During the First Year of Application
Felix Dietlein, Melanie Hohberg, Carsten Kobe, et al.
EJNMMI Research
|
January 10, 2025
Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy
Jan Heilinger, Katrin Sabine Roth, Henning Weis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 3, 2016
PSA-Stratified Performance of <sup>18</sup>F- and <sup>68</sup>Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer
Felix Dietlein, Carsten Kobe, Stephan Neubauer, et al.
Nature Communications
|
August 27, 2016
The tumour suppressor CYLD regulates the p53 DNA damage response
Vanesa Fernández-Majada, Patrick-Simon Welz, Maria A Ermolaeva, et al.
Cancer Discovery
|
February 22, 2014
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC
Felix Dietlein, Lisa Thelen, Mladen Jokic, et al.
International Journal of Molecular Sciences
|
October 16, 2024
Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [<sup>131</sup>I]-Iodine-ERIC1 in Neuroblastoma-Bearing Mice
Thomas Fischer, Felix Dietlein, Detlev Bongartz, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Molecular Imaging and Biology
|
October 2, 2020
[<sup>18</sup>F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer
Felix Dietlein, Peter Mueller, Carsten Kobe, et al.
Nature Genetics
|
February 5, 2020
Identification of cancer driver genes based on nucleotide context
Felix Dietlein, Donate Weghorn, Amaro Taylor-Weiner, et al.
Molecular Imaging and Biology
|
August 9, 2021
Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer
Sergio Muñoz Vázquez, Heike Endepols, Thomas Fischer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
An <sup>89</sup>Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients
Felix Dietlein, Carsten Kobe, Sergio Muñoz Vázquez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 21, 2019
An <sup>18</sup>F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with <sup>18</sup>F-JK-PSMA-7 During the First Year of Application
Felix Dietlein, Melanie Hohberg, Carsten Kobe, et al.
EJNMMI Research
|
January 10, 2025
Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy
Jan Heilinger, Katrin Sabine Roth, Henning Weis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 3, 2016
PSA-Stratified Performance of <sup>18</sup>F- and <sup>68</sup>Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer
Felix Dietlein, Carsten Kobe, Stephan Neubauer, et al.
Nature Communications
|
August 27, 2016
The tumour suppressor CYLD regulates the p53 DNA damage response
Vanesa Fernández-Majada, Patrick-Simon Welz, Maria A Ermolaeva, et al.
Cancer Discovery
|
February 22, 2014
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC
Felix Dietlein, Lisa Thelen, Mladen Jokic, et al.
International Journal of Molecular Sciences
|
October 16, 2024
Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [<sup>131</sup>I]-Iodine-ERIC1 in Neuroblastoma-Bearing Mice
Thomas Fischer, Felix Dietlein, Detlev Bongartz, et al.
Page
of 5